Through gene-silencing techniques, including siRNA or shRNA, the expression of COX-2 can be specifically inhibited, which reduces the secretion of pro-inflammatory cytokines, thereby decreasing the proliferation and invasiveness of tumor cells. This evidence concerns the gene PTGS2 and neoplasm.